Recent News

• 03.10.2025 - Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
• 02.24.2025 - Insmed Announces that FDA Does Not Currently Plan to Hold Advisory Committee Meeting to Discuss New Drug Application for Brensocatib in Patients with Bronchiectasis
• 02.20.2025 - Insmed Reports Fourth-Quarter and Full-Year 2024 Financial Results and Provides Business Update
• 02.11.2025 - Insmed To Present at March 2025 Investor Conferences

Recent Filings

• 03.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.03.2025 - 144 Report of proposed sale of securities
• 02.27.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.24.2025 - 8-K Current report
• 02.24.2025 - EX-99.1 EX-99.1
• 02.20.2025 - EX-99.1 EX-99.1
• 02.20.2025 - 8-K Current report
• 02.20.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 02.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.20.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]